Available in 2 stacks save up to 120,00 Lean Mass - Startsave 40,00 View the stack Lean Mass - Advancedsave 120,00 View the stack BPC-157 & TB-500 - Targeted Repair & Systemic Regeneration Promotes repair of tendons, ligaments, and muscles through improved fibroblast activity Supports angiogenesis and collagen formation in experimental injury models Stimulates new blood vessel growth and nutrient delivery to damaged tissues Modulates inflammatory cytokines and oxidative stress response Shortens experimental recovery times in models of physical injury Strengthens connective structures and promotes elasticity Encourages organized collagen fiber alignment for stronger repair Activates signaling linked to cytoskeletal renewal and angiogenic response Description BPC-157 (Body Protection Compound-157) is a gastric-derived pentadecapeptide shown in preclinical studies to accelerate the healing of tendons, ligaments, muscles, and intestinal tissues
Current findings regarding CJC-1134-PC, which is a conjugate of exendin-4 and recombinant human albumin and represents a once-weekly glucagon-like peptide-1 receptor agonist, suggest that it provides similar reduction in body weight compared with exenatide twice-daily
Vitamin B12 deficiency is most likely to develop in animals with reduced cobalamin absorption due to gastrointestinal disease and in dogs with pancreatic enzyme insufficiency (which is more common in certain breeds)
Research demonstrating GHK-Cus wound healing effects provides compelling evidence for systemic distribution
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
